Novo Nordisk mentioned Wednesday that it has elevated the provision of the bottom dose of its blockbuster weight loss drug Wegovy, which it claims will permit more people within the U.S. to get started on taking the drug. But the identical scientific trials also display that just below 14% don’t lose weight, plus some might even acquire weight.